Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableLooking for participantsNCT05633056
What this trial is testing

An Adaptive Randomized Controlled Trial

Who this might be right for
Multi Drug Resistant TuberculosisHIV Infections
Columbia University 360
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Testing effectiveness (Phase 2)Ended earlyNCT03331445
What this trial is testing

Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections

Who this might be right for
Respiratory Tract InfectionsCorona Virus Infection
Chris Miller 13
Large-scale testing (Phase 3)Study completedNCT02754765
What this trial is testing

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Who this might be right for
Tuberculosis, Multidrug-ResistantInfection, BacterialPulmonary Tuberculoses
Médecins Sans Frontières, France 754
Not applicableStudy completedNCT02597621
What this trial is testing

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 192
Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableStudy completedNCT02727582
What this trial is testing

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

Who this might be right for
Multidrug-resistant Tuberculosis
University of Cape Town 142
Testing effectiveness (Phase 2)Ended earlyNCT04575519
What this trial is testing

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, MDRTuberculosis Infection
Fundació Institut Germans Trias i Pujol 426
Testing effectiveness (Phase 2)Study completedNCT02821832
What this trial is testing

Using Biomarkers to Predict TB Treatment Duration

Who this might be right for
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 946
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Not applicableUnknownNCT05359315
What this trial is testing

Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
SPP Pharmaclon Ltd. 84
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableStudy completedNCT02534727
What this trial is testing

Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance

Who this might be right for
TuberculosisNon-Tuberculosis Mycobacteria
National Institute of Allergy and Infectious Diseases (NIAID) 215
Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Next Page